Snowball logo
logo
NONO_logo

Novo Nordisk A/S

$45.71-$1.20Β  (2.56%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
924,816.6176,954232,261290,403308,364329,251.7
COGS
155,392.828,44835,76544,52260,621.463,750
Gross Profit
769,423.8148,506196,496245,881247,742.6265,681
Operating Expenses & Income
Operating Income
385,191.474,809102,574128,339134,713.2142,097
Total Operating Expenses
384,232.473,69793,922117,542113,029.4123,584
R&D Expenses
116,731.824,04732,44348,06245,119.658,078.8
Selling General & Admin Expenses
26,601.64,4674,8555,2765,9695,325
Earnings from Continuing Operations
Interest Expense
(1,898.2)(378)(739)(1,640)(4,214.4)927.6
Interest Income
1,517.32391,0691,8381,26916,979
Income Tax Expense
74,372.913,53720,99126,20328,042.332,289.5
Net Income
Net Income
313,682.355,52583,683100,988102,202116,382.1
Supplemental
EBIT
390,912.471,496105,216128,831134,467.7156,318.6
EBITDA
425,796.676,802111,041137,376149,100.5178,945
In millions of USD, except % and values per 1 share